Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding

The Serum Institute of India (SII) is set to manufacture clinical trial doses of an experimental Ebola vaccine being developed by the University of Oxford, after the Coalition for Epidemic Preparedness Innovations (CEPI) announced fresh funding to accelerate efforts against the rapidly spreading Bundibugyo ebolavirus outbreak in Africa.

CEPI said it has committed up to $8.6 million to support preclinical testing and early-stage development of the Oxford vaccine candidate, with manufacturing of clinical-grade doses to be carried out by Pune-based SII.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.